HungaryHungary

GMO crops ploughed under

09.08.2011

Budapest/Kraków – In July, illegally planted genetically modified crops made headlines in Hungary, where GMO acreage is banned. Up to 0.1% GMO maize products from Monsanto and Pioneer were discovered at four sites (near Szigetvar, Letavertes, Szolnok and Fejer county). This despite a new regulation that came into effect last March stipulating seed checks, and in spite of the law that seed firms are obliged to check seeds for GMOs before shipping.
In mid-July, Deputy State Secretary Lajos Bognar from the Hungarian Ministry of Rural Development ordered that the affected crops be destroyed. An area of about 1,000 hectares was affected, and it remains as yet unclear if other seeds provided to farmers by a Hungarian seed distributor and planted on an additional 2,500 hectares also contained GM maize. The farmers, who were unaware they were planting GMOs, said they stand to lose their complete harvest because it’s now too late to sow maize again this year. Monsanto has denied any responsibility, saying that every conventional seed batch is checked for GMO admixture before it is shipped. Monsanto has refused to pay any compensation to farmers, but has told the government the company will buy back any seeds it thinks are “GMO-infected”. It looks unlikely that farmers will receive any compensation, because the Hungarian distributor is under liquidation, and any possible damages will be paid primarily to its creditors.

Polish fear new legislation sets stage for flood of GMOs

At the end of July, hundreds of GMO protestors hit the street in Warsaw and Kraków to demonstrate against a new seed act, later passed by the Sejm, which aims to adjust Polish regulations to EU directives. Critics say the act indirectly creates a loophole that allows farmers to circumvent the existing marketing and cultivation ban by allowing GMO seeds to enter the national seed registry and to be imported from abroad.

HungaryHungary

20.09.2009

Budapest – Mecsek Pharma has won a HUF1bn (EUR3.6m) state grant that will allow the company to test the insulin sensitiser BGT-15 in a Phase IIb clinical trial, according to Mecsek’s parent company Phylaxia Holding. BGT-15 is a...

HungaryHungary

12.09.2009

Budapest – California-based biotech company Codexis plans to expand its expertise in fermentation technology. In August, Codexis’ CEO Alan Shaw announced that the firm will expand its activities in fermentation technology in...

HungaryHungary

13.07.2009

Budapest – UK clinical research organisation Chiltern International Ltd has opened a new office in Budapest. The branch will be led by Dr. Attila Lorinczi , a member of the Hungarian Medical Society and the Society of Hungarian...

HungaryHungary

29.04.2009

Budapest – The European Institute of Innovation and Technology (EIT) launched a call for proposals for its first Knowledge and Innovation Communities (KICs) at the beginning of April (http://eit.europa.eu). The call will remain...

HungaryHungary

05.11.2008

Budapest/Brussels – The Budapest-based European Institute of Technology (EIT, http://eit.europa.eu) has received its first governing board. The 18 members, who held the board’s inaugural meeting on the occasion of the EIT’s...

HungaryHungary

20.10.2008

Debrecen/Budapest – Hungary’s leading pharmaceutical company Gedeon Richter Plc. is continuing to expand its activities in biotechnological R&D and manufacturing of therapeutic proteins. After the establishment of Richter-Helm in...

HungaryHungary

18.08.2008

Budapest/Brussels – The European research ministers decided in mid-June that the Hungarian capital Budapest will house the headquarters of the prestigious European Institute of Technology (EIT). With a budget of EUR308m until...

HungaryHungary

14.08.2008

Geneva – Ernesto Bertarelli, the Swiss-Italian biotech billionaire who sold his company Serono SA, has returned to the front lines of the pharma business as his new EUR1bn healthcare fund joined with Merrill Lynch to buy...

HungaryHungary

20.05.2008

Bucharest – Three years ago, Romania was Europe’s largest cultivator of genetically modified plants (87,600 hectares of GM soy acreage). With acession, the government there had to halt the cultivation of the GM crops not approved...

HungaryHungary

19.03.2008

Zagreb – Pliva d.d., Barr Pharmaceuticals‘ subsidiary in Croatia, is selling its three operations in Spain – Pliva Pharma Iberia, Laboratorios Edigen and Uso Racional – to Biomedica Foscama Industria Chimico-Farmaceutica. For a...

Displaying results 11 to 20 out of 89

< Previous 11-20 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-hungary/browse/1/article/gmo-crops-ploughed-under.html

Product of the week

Products

Events

All Events

Current issue

All issues